What’s inside: monitoring · access rules
The question this file answersHow much of our pharmacist's morning goes on repeats that were never going to need them?
Fits: providers where results, scripts and traceability paperwork wait on manual filing.
Typical pattern, not a measured pharmacy — the healthcare playbook publishes no volume for dispensing admin, so this desk carries none. Every prescription sits in one queue: repeats already on the shelf beside a new interaction query. The pharmacist reads them in order of arrival, which is nobody's order of risk.
First thing, the pharmacist opens the interventions and queries at the top of the queue, then works through routine repeats already confirmed in stock. Every script is still checked by the pharmacist; the order of the morning is what changes.
Typical, not a measured client result. Every figure here comes from the playbook source named below.
the queue re-ordered by risk, every check still the pharmacist's — no published figure for this desk
Before: repeats that are already in stock wait in the same queue as interventions. After: the queue is ordered by risk and the pharmacist still checks every script. Dispensing admin has no published figure, and we do not borrow one.
Pharmacy dispensing admin has no published benchmark, so nothing here is a percentage. In-stock, in-protocol repeats move first; every clinical check and intervention stays the pharmacist's.
We change nothing in the pharmacy system or the EHR — Epic, Cerner, whatever you run. The re-ordering logic is the one in our lab-results file, applied to the dispensing queue:
The clinical check on every script. Interventions. The conversation at the counter.
Stock records that lag the shelf produce 'in-stock' repeats that are not; those become a walk to the shelf, not a rule. Handwritten or faxed scripts are read less reliably and go to review by default. There is no published figure for dispensing admin; the Accenture lab-results figure on the parent file is not transferred, and no clinical check is removed.
The path: free 60-second estimate → free 20-minute review → paid audit of this one process (€1.5–3K, typically two weeks) → pilot with your people in the loop (€10–20K, weeks, not quarters). No transformation programme. Prices are public, on the services page →
Scoped in the audit — the playbook has no estimate for this exact desk.
That depends on your volumes and wage costs — this page will not invent the number. The free 60-second estimate runs that calculation from your answers, with every multiplier sourced.
Not a named Aperanda client. Process file · Healthcare.
Short process file. Same build as its parent file; the playbook has no separate volume or benchmark for this desk.